Literature DB >> 4315612

Neutralization of sensitized virus by purified components of complement.

C A Daniels, T Borsos, H J Rapp, R Snyderman, A L Notkins.   

Abstract

Herpes simplex virus which had been sensitized with immunoglobulin M antibody was neutralized by serum deficient in the fifth and sixth components of complement (C) but not by serum deficient in the fourth component C (C4). The sequential addition of the functionally purified components of C showed that the activated first component of C (C1[unk]) failed to neutralize sensitized virus. However, in the presence of an optimal concentration of C1[unk], the addition of C4 resulted in neutralization. The amount of virus neutralized was dependent upon the concentration of immunoglobulin M used to sensitize the virus and the concentration of C1[unk] and C4. The addition of the second component of C (C2) to reaction mixtures containing an optimal concentration of C1[unk] and a limiting concentration of C4 resulted in increased neutralization and the amount of virus neutralized was dependent upon the concentration of C2. The addition of the third component of C (C3) to reaction mixtures containing an optimal concentration of C1[unk] and limiting concentrations of C4 and C2 also resulted in increased neutralization and the amount of virus neutralized was dependent upon the concentration of C3.

Mesh:

Substances:

Year:  1970        PMID: 4315612      PMCID: PMC282939          DOI: 10.1073/pnas.65.3.528

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. 3. MECHANISM OF THE ANTIBODY-POTENTIATING ACTION OF COMPLEMENT.

Authors:  K YOSHINO; S TANIGUCHI
Journal:  Virology       Date:  1965-05       Impact factor: 3.616

2.  Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin.

Authors:  W K Ashe; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

3.  Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus.

Authors:  B Hampar; A L Notkins; M Mage; M A Keehn
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

4.  Herpes simplex neutralizing antibody--quantitation of the complement-dependent fraction in different phases of adult human infection.

Authors:  H S Heineman
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

5.  Neutralization of sensitized virus by the fourth component of complement.

Authors:  C A Daniels; T Borsos; H J Rapp; R Snyderman; A L Notkins
Journal:  Science       Date:  1969-08-01       Impact factor: 47.728

6.  The morphological and biological effects of various antisera on avian infectious bronchitis virus.

Authors:  D M Berry; J D Almeida
Journal:  J Gen Virol       Date:  1968-07       Impact factor: 3.891

7.  Ultrastructural localization of the third and fourth components of complement on complement-cell complexes.

Authors:  M R Mardiney; H J Müller-Eberhard; J D Feldman
Journal:  Am J Pathol       Date:  1968-08       Impact factor: 4.307

8.  Complement research. Fundamental and applied.

Authors:  H J Rapp; T Borsos
Journal:  JAMA       Date:  1966-12-26       Impact factor: 56.272

9.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

10.  Infectious virus-antibody complex in the blood of chronically infected mice.

Authors:  A L Notkins; S Mahar; C Scheele; J Goffman
Journal:  J Exp Med       Date:  1966-07-01       Impact factor: 14.307

View more
  38 in total

1.  Neutralizing determinants of canine herpesvirus as defined by monoclonal antibodies.

Authors:  X Xuan; T Horimoto; J A Limcumpao; A Takumi; Y Tohya; E Takahashi; T Mikami
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Enhancement by diethylamineothyl-dextran of the plaque-forming activity of foot-and-mouth disease virus-antibody complexes in pig kidney IB-RS-2 cells.

Authors:  J C Booth
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

3.  Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

Authors:  H E Jasin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

4.  Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

Authors:  E C Böttger; T Hoffmann; U Hadding; D Bitter-Suermann
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

5.  Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles.

Authors:  G Uko; F T Christiansen; R L Dawkins; V J McCann
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

6.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Inherited deficiency of the second component of complement. Rheumatic disease associations.

Authors:  D Glass; D Raum; D Gibson; J S Stillman; P H Schur
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

8.  Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.

Authors:  Erin Mehlhop; Steevenson Nelson; Christiane A Jost; Sergey Gorlatov; Syd Johnson; Daved H Fremont; Michael S Diamond; Theodore C Pierson
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

9.  Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

Authors:  G R Nemerow; F C Jensen; N R Cooper
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Mouse model for abortive rabies infection of the central nervous system.

Authors:  J S Smith
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.